ADMA Biologics says updated IVIG process removes clot-linked impurities, raises yield in three-lot study

ADMA Biologics says a three-lot study shows its updated IVIG process removes clot-linked impurities and raises yield, with no clotting events reported through July 2026.

Detected & updated continuously · Source: Nebula